Charles Schwab Investment Management Inc Cassava Sciences Inc Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 361,797 shares of SAVA stock, worth $850,222. This represents 0.0% of its overall portfolio holdings.

Number of Shares
361,797
Previous 351,368 2.97%
Holding current value
$850,222
Previous $4.34 Million 145.38%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$9.57 - $35.08 $99,805 - $365,849
10,429 Added 2.97%
361,797 $10.6 Million
Q2 2024

Aug 12, 2024
BUY
$12.35 - $26.11 $431,965 - $913,249
34,977 Added 11.05%
351,368 $4.34 Million
Q1 2024

May 08, 2024
BUY
$18.44 - $26.41 $139,314 - $199,527
7,555 Added 2.45%
316,391 $6.42 Million
Q4 2023

Feb 06, 2024
BUY
$12.64 - $30.11 $52,013 - $123,902
4,115 Added 1.35%
308,836 $6.95 Million
Q3 2023

Nov 08, 2023
BUY
$16.64 - $25.32 $154,984 - $235,830
9,314 Added 3.15%
304,721 $5.07 Million
Q2 2023

Aug 09, 2023
BUY
$21.59 - $27.88 $99,119 - $127,997
4,591 Added 1.58%
295,407 $7.24 Million
Q1 2023

May 11, 2023
BUY
$23.46 - $36.44 $251,139 - $390,090
10,705 Added 3.82%
290,816 $7.01 Million
Q4 2022

Feb 13, 2023
BUY
$27.82 - $44.16 $143,912 - $228,439
5,173 Added 1.88%
280,111 $8.27 Million
Q3 2022

Nov 14, 2022
BUY
$16.33 - $51.06 $119,649 - $374,116
7,327 Added 2.74%
274,938 $11.5 Million
Q2 2022

Aug 15, 2022
SELL
$17.22 - $38.47 $109,364 - $244,322
-6,351 Reduced 2.32%
267,611 $7.53 Million
Q1 2022

May 13, 2022
BUY
$32.6 - $53.05 $210,661 - $342,809
6,462 Added 2.42%
273,962 $10.2 Million
Q4 2021

Feb 11, 2022
BUY
$36.77 - $90.91 $191,534 - $473,550
5,209 Added 1.99%
267,500 $11.7 Million
Q3 2021

Nov 16, 2021
BUY
$41.79 - $135.3 $6.99 Million - $22.6 Million
167,214 Added 175.87%
262,291 $16.3 Million
Q2 2021

Aug 16, 2021
BUY
$32.15 - $89.72 $387,118 - $1.08 Million
12,041 Added 14.5%
95,077 $8.12 Million
Q1 2021

May 17, 2021
BUY
$7.09 - $87.95 $41,497 - $514,771
5,853 Added 7.58%
83,036 $3.73 Million
Q4 2020

Feb 16, 2021
BUY
$6.79 - $12.25 $137,470 - $248,013
20,246 Added 35.56%
77,183 $527,000
Q3 2020

Nov 13, 2020
BUY
$2.86 - $11.51 $20,020 - $80,570
7,000 Added 14.02%
56,937 $656,000
Q2 2020

Aug 14, 2020
BUY
$2.04 - $9.64 $101,871 - $481,392
49,937 New
49,937 $154,000

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $94.2M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email